中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
D-1/d-2 dopamine receptor interaction in membrane abolished by 6-hydroxydopamine lesion

文献类型:期刊论文

作者Guo, X; Zou, LL; Jin, GZ
刊名Life sciences
出版日期1998-05-29
卷号63期号:1页码:Pl7-pl12
关键词Spiperone Sch23390 Radioligand assay D-1/d-2 interaction 6-hydroxydopamine
ISSN号0024-3205
通讯作者Jin, gz()
英文摘要D-1/d-2 interaction in rat striatum was investigated by examining the effect of the d-2 antagonist spiperone on the binding of [h-3]sch23390 to d-1 dopamine (da) receptors. in the presence of endogenous da, spiperone blocked d-2 receptors, then caused the increase of the binding of [h-3]sch23390 in rat striatal homogenate. after the 6-hydroxydopamine (6-ohda) lesion, the increase was not found even if in the addition of exogenous da. the results suggest that the d-2 antagonist can modify the interaction between endogenous da and d-1 receptors labeled with [h-3]sch23390, while 6-ohda lesion may change the state of d-1/d-2 interaction operating at the receptor level. (c) 1998 elsevier science inc.
WOS关键词D-2 RECEPTORS ; STIMULATION ; ANTAGONISTS ; AGONISTS ; BRAIN ; RATS ; LINK ; D1
WOS研究方向Research & Experimental Medicine ; Pharmacology & Pharmacy
WOS类目Medicine, Research & Experimental ; Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000074036000010
出版者PERGAMON-ELSEVIER SCIENCE LTD
URI标识http://www.irgrid.ac.cn/handle/1471x/2376038
专题武汉病毒研究所
通讯作者Jin, GZ
作者单位Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol, Shanghai 200031, Peoples R China
推荐引用方式
GB/T 7714
Guo, X,Zou, LL,Jin, GZ. D-1/d-2 dopamine receptor interaction in membrane abolished by 6-hydroxydopamine lesion[J]. Life sciences,1998,63(1):Pl7-pl12.
APA Guo, X,Zou, LL,&Jin, GZ.(1998).D-1/d-2 dopamine receptor interaction in membrane abolished by 6-hydroxydopamine lesion.Life sciences,63(1),Pl7-pl12.
MLA Guo, X,et al."D-1/d-2 dopamine receptor interaction in membrane abolished by 6-hydroxydopamine lesion".Life sciences 63.1(1998):Pl7-pl12.

入库方式: iSwitch采集

来源:武汉病毒研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。